Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

Europe Molecular Diagnostics Market

$1500

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services.

Publisher’s Note: Reports from KBV Research comes with a powerful Market Research & Analytics tool which facilitates the client to see data graphically. Request a free demo of the Market Research & Analytics Tool here.
Report DescriptionResearch ScopeTable of ContentPricing

Europe Molecular Diagnostics Market Overview

Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

In Europe, Advances in Prenatal Molecular Diagnostics, Biomarkers for Immunotherapy, Advanced diagnostics for Infectious diseases, Point to care diagnostics, Cell free DNA in clinical oncology is playing vital role in the growth of molecular diagnostics market. According to the fourth conference on molecular diagnostics Europe held in 2016, it has been stated that arrays and next-gen sequencing are playing an increased role in the level of invasive technology. Also, it is contributing towards the increasing demand for DNA. In Addition, Cambridge Healthtech Institute has designed Inaugural Biomarkers for Immunotherapy. On the other side many health companies are also offering new range of products with molecular technologies. For Example: Siemens Healthcare has also launched its new product with new VERSANT® kPCR Molecular System. This product improves workflow and consolidation and allows multiple assays per sample and run. Recently, Microbix has also launched new range of products in molecular diagnostics. Hence, it could be expected that innovative technology could be leading the growth of molecular diagnostics market in Europe.

Europe Molecular Diagnostics Market Segmentation

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers. Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Germany, UK, France, Russia, Spain and Italy.

Europe Molecular Diagnostics Market Key Companies

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report includeAbbott Laboratories,Qiagen N.V,Roche Diagnostics,Grifols,Siemens Healthcare (Siemens AG),Becton Dickinson and Company and Danaher Corporation.

Europe Molecular Diagnostics Market Segmentation

Market Segmentation:

By Product & Services

  • Reagents & Kits
  • Instruments
  • Software& Services

By Technology

  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Hybridization
  • DNA Sequencing & Next-Generation Sequencing
  • Microarray
  • Other Technologies

By Application

  • Infectious Diseases
    • Chlamydia Trachomatis & Neisseria Gonorrhoea
    • Hepatitis B & Hepatitis C
    • Human Papillomavirus
    • Human Immunodeficiency Virus
    • Tuberculosis
    • Methicillin-Resistant Staphylococcus Aurous
    • Others
  • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Other Cancers
  • Blood Screening
  • Genetic Tests
  • Microbiology
  • Other Applications

By End User

  • Hospital & Academic Laboratories
  • Reference Laboratories
  • Other End Users

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Company Profiled

  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage of EuropeMolecular Diagnostics Market
  • Highest number of market tables
  • Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
  • Subscription based model available
  • Free of cost quarterly updates
  • Free of cost automatic pdf report generation
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Chapter 1.  Market Scope & Methodology

1.1  Market Definition

1.2  Objectives

1.3  Market Scope

1.4  Segmentation

1.4.1  Europe Molecular Diagnostics Market, by Product & Services

1.4.2  Europe Molecular Diagnostics Market, by Technology

1.4.3  Europe Molecular Diagnostics Market, by Application

1.4.4  Europe Molecular Diagnostics Market, by End User

1.4.5  Europe Molecular Diagnostics Market, by Country

1.5  Methodology for the research

Chapter 2.  Executive Summary

Chapter 3.  Market Overview

3.1  Introduction

3.2  Drivers, Restraints and Opportunities

3.2.1  Market Drivers

3.2.2  Market Restraints

Chapter 4.  Europe Molecular Diagnostics Market

4.1  Europe Molecular Diagnostics Market by Product & Services

4.1.1  Europe Molecular Diagnostics Reagents & Kits Market by Country

4.1.2  Europe Molecular Diagnostics Instruments Market by Country

4.1.3  Europe Molecular Diagnostics Software & Services Market by Country

Chapter 5.  Europe Molecular Diagnostics Market by Technology

5.1  Introduction

5.1.1  Europe Polymerase Chain Reaction Molecular Diagnostics Market by Country

5.1.2  Europe Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country

5.1.3  Europe Hybridization Molecular Diagnostics Market by Country

5.1.4  Europe DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country

5.1.5  Europe Microarray Molecular Diagnostics Market by Country

5.1.6  Europe Other Technologies Market by Country

Chapter 6.  Europe Molecular Diagnostics Market by Application

6.1  Introduction

6.1.1  Europe Infectious Diseases Molecular Diagnostics Market by Country

6.1.2  Europe Infectious Diseases Molecular Diagnostics Market by Type

6.1.2.1  Europe Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country

6.1.2.2  Europe Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country

6.1.2.3  Europe Human Papillomavirus Molecular Diagnostics Market by Country

6.1.2.4  Europe Human Immunodeficiency Virus Molecular Diagnostics Market by Country

6.1.2.5  Europe Tuberculosis Molecular Diagnostics Market by Country

6.1.2.6  Europe Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country

6.1.2.7  Europe Molecular Diagnostics in Other Infectious Diseases Market by Country

6.1.3  Europe Oncology Molecular Diagnostics Market by Country

6.1.4  Europe Oncology Molecular Diagnostics Market by Type

6.1.4.1  Europe Breast Cancer Molecular Diagnostics Market by Country

6.1.4.2  Europe Colorectal Cancer Molecular Diagnostics Market by Country

6.1.4.3  Europe Prostate Cancer Molecular Diagnostics Market by Country

6.1.4.4  Europe Other Cancers Molecular Diagnostics Market by Country

6.1.5  Europe Blood Screening Molecular Diagnostics Market by Country

6.1.6  Europe Genetic Tests Molecular Diagnostics Market by Country

6.1.7  Europe Microbiology Molecular Diagnostics Market by Country

6.1.8  Europe Other Applications Market by Country

Chapter 7.  Europe Molecular Diagnostics Market by End User

7.1  Introduction

7.1.1  Europe Molecular Diagnostics Market for Hospital & Academic Laboratories by Country

7.1.2  Europe Molecular Diagnostics Market for Reference Laboratories by Country

7.1.3  Europe Molecular Diagnostics Market for Other End Users by Country

Chapter 8.  Europe Molecular Diagnostics Market by Country

8.1  Introduction

8.2  Germany Molecular Diagnostics Market

8.2.1  Germany Molecular Diagnostics Market by Product & Services

8.2.2  Germany Molecular Diagnostics Market by Technology

8.2.3  Germany Molecular Diagnostics Market by Application

8.2.3.1  Germany Infectious Diseases Molecular Diagnostics Market by Type

8.2.3.2  Germany Oncology Molecular Diagnostics Market by Type

8.2.4  Germany Molecular Diagnostics Market by End User

8.3  UK Molecular Diagnostics Market

8.3.1  UK Molecular Diagnostics Market by Product & Services

8.3.2  UK Molecular Diagnostics Market by Technology

8.3.3  UK Molecular Diagnostics Market by Application

8.3.3.1  UK Infectious Diseases Molecular Diagnostics Market by Type

8.3.3.2  UK Oncology Molecular Diagnostics Market by Type

8.3.4  UK Molecular Diagnostics Market by End User

8.4  France Molecular Diagnostics Market

8.4.1  France Molecular Diagnostics Market by Product & Services

8.4.2  France Molecular Diagnostics Market by Technology

8.4.3  France Molecular Diagnostics Market by Application

8.4.3.1  France Infectious Diseases Molecular Diagnostics Market by Type

8.4.3.2  France Oncology Molecular Diagnostics Market by Type

8.4.4  France Molecular Diagnostics Market by End User

8.5  Russia Molecular Diagnostics Market

8.5.1  Russia Molecular Diagnostics Market by Product & Services

8.5.2  Russia Molecular Diagnostics Market by Technology

8.5.3  Russia Molecular Diagnostics Market by Application

8.5.3.1  Russia Infectious Diseases Molecular Diagnostics Market by Type

8.5.3.2  Russia Oncology Molecular Diagnostics Market by Type

8.5.4  Russia Molecular Diagnostics Market by End User

8.6  Spain Molecular Diagnostics Market

8.6.1  Spain Molecular Diagnostics Market by Product & Services

8.6.2  Spain Molecular Diagnostics Market by Technology

8.6.3  Spain Molecular Diagnostics Market by Application

8.6.3.1  Spain Infectious Diseases Molecular Diagnostics Market by Type

8.6.3.2  Spain Oncology Molecular Diagnostics Market by Type

8.6.4  Spain Molecular Diagnostics Market by End User

8.7  Italy Molecular Diagnostics Market

8.7.1  Italy Molecular Diagnostics Market by Product & Services

8.7.2  Italy Molecular Diagnostics Market by Technology

8.7.3  Italy Molecular Diagnostics Market by Application

8.7.3.1  Italy Infectious Diseases Molecular Diagnostics Market by Type

8.7.3.2  Italy Oncology Molecular Diagnostics Market by Type

8.7.4  Italy Molecular Diagnostics Market by End User

8.8  Rest of Europe Molecular Diagnostics Market

8.8.1  Rest of Europe Molecular Diagnostics Market by Product & Services

8.8.2  Rest of Europe Molecular Diagnostics Market by Technology

8.8.3  Rest of Europe Molecular Diagnostics Market by Application

8.8.3.1  Rest of Europe Infectious Diseases Molecular Diagnostics Market by Type

8.8.3.2  Rest of Europe Oncology Molecular Diagnostics Market by Type

8.8.4  Rest of Europe Molecular Diagnostics Market by End User

Chapter 9.  Company Profiles

9.1  Abbott Laboratories

9.1.1  Company Overview

9.1.2  Financial Analysis

9.1.3  Segmental and Regional Analysis

9.1.4  Research & Development Expense

9.2  Qiagen N.V.

9.2.1  Company Overview

9.2.2  Financial Analysis

9.2.3  Segmental and Regional Analysis

9.2.4  Research & Development Expense

9.3  Roche Diagnostics

9.3.1  Company Overview

9.3.2  Financial Analysis

9.3.3  Segmental and Regional Analysis

9.3.4  Research & Development Expense

9.4  Grifols

9.4.1  Company Overview

9.4.2  Financial Analysis

9.4.3  Segmental and Regional Analysis

9.5  Siemens Healthcare (Siemens AG)

9.5.1  Company Overview

9.5.2  Financial Analysis

9.5.3  Segmental and Regional Analysis

9.5.4  Research & Development Expense

9.6  Becton Dickinson and Company

9.6.1  Company Overview

9.6.2  Financial Analysis

9.6.3  Segmental and Regional Analysis

9.6.4  Research & Development Expense

9.7  Danaher Corporation

9.7.1  Company Overview

9.7.2  Financial Analysis

9.7.3  Segmental and Regional Analysis

9.7.4  Research & Development Expense

LIST OF TABLES

TABLE 1  EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 2  EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 3  EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 4  EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 5  EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 6  EUROPE MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 7  EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 8  EUROPE MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 9  EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 10  EUROPE MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 11  EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 12  EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 13  EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 14  EUROPE POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 15  EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 16  EUROPE ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 17  EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 18  EUROPE HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 19  EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 20  EUROPE DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 21  EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 22  EUROPE MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 23  EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 24  EUROPE OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 25  EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 26  EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 27  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 28  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 29  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 30  EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 31  EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 32  EUROPE CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 33  EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 34  EUROPE HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 35  EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 36  EUROPE HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 37  EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 38  EUROPE HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 39  EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 40  EUROPE TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 41  EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 42  EUROPE METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 43  EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 44  EUROPE MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 45  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 46  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 47  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 48  EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 49  EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 50  EUROPE BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 51  EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 52  EUROPE COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 53  EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 54  EUROPE PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 55  EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 56  EUROPE OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 57  EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 58  EUROPE BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 59  EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 60  EUROPE GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 61  EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 62  EUROPE MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 63  EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 64  EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 65  EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 66  EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 67  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 68  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 69  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 70  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 71  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 72  EUROPE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 73  EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 74  EUROPE MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 75  GERMANY MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 76  GERMANY MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 77  GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 78  GERMANY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 79  GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 80  GERMANY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 81  GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 82  GERMANY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 83  GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 84  GERMANY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 85  GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 86  GERMANY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 87  GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 88  GERMANY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 89  UK MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 90  UK MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 91  UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 92  UK MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 93  UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 94  UK MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 95  UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 96  UK MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 97  UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 98  UK INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 99  UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 100  UK ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 101  UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 102  UK MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 103  FRANCE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 104  FRANCE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 105  FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 106  FRANCE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 107  FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 108  FRANCE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 109  FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 110  FRANCE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 111  FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 112  FRANCE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 113  FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 114  FRANCE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 115  FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 116  FRANCE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 117  RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 118  RUSSIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 119  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 120  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 121  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 122  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 123  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 124  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 125  RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 126  RUSSIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 127  RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 128  RUSSIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 129  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 130  RUSSIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 131  SPAIN MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 132  SPAIN MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 133  SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 134  SPAIN MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 135  SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 136  SPAIN MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 137  SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 138  SPAIN MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 139  SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 140  SPAIN INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 141  SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 142  SPAIN ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 143  SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 144  SPAIN MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 145  ITALY MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 146  ITALY MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 147  ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 148  ITALY MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 149  ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 150  ITALY MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 151  ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 152  ITALY MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 153  ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 154  ITALY INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 155  ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 156  ITALY ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 157  ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 158  ITALY MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 159  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 160  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 161  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 162  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 163  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 164  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 165  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 166  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 167  REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 168  REST OF EUROPE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 169  REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 170  REST OF EUROPE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 171  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 172  REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 173  KEY INFORMATION – ABBOTT LABORATORIES.

TABLE 174  KEY INFORMATION – QUIAGEN N.V.

TABLE 175  KEY INFORMATION – ROCHE DIAGNOSTIC

TABLE 176  KEY INFORMATION – GRIFOLS

TABLE 177  KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)

TABLE 178  KEY INFORMATION – BECTON DICKINSON AND COMPANY

TABLE 179  KEY INFORMATION – DANAHER CORPORATION


LICENSE TYPE